Table 2 Univariate and multivariate analyses of the factors correlated with Overall survival of Liver carcinoma patients
From: Prognostic biomarker SMARCC1 and its association with immune infiltrates in hepatocellular carcinoma
Variables | Univariate analysis | Multivariate analysis | ||||
|---|---|---|---|---|---|---|
HR | 95%CI | P value | HR | 95%CI | P value | |
SMARCC1 Expression | 2.458 | 1.239–4.873 | 0.010 | 2.554 | 1.271–5.133 | 0.008 |
Age | 1.150 | 0.626–2.110 | 0.652 |  |  |  |
Sex | 1.013 | 0.451–2.272 | 0.976 |  |  |  |
Grade | 0.880 | 0.467–1.660 | 0.694 |  |  |  |
T stage | 2.362 | 1.302–4.286 | 0.005 | 0.422 | 0.125–1.430 | 0.166 |
TNM stage | 1.958 | 1.391–2.756 | 0.000 | 3.151 | 1.501–6.613 | 0.002 |
cirrhosis | 1.788 | 0.931–3.434 | 0.081 |  |  |  |
Hep | 2.434 | 0.335–17.693 | 0.379 |  |  |  |
AFP# | 1.236 | 0.641–2.384 | 0.528 |  |  |  |
CK19# | 1.252 | 0.670–2.338 | 0.481 |  |  |  |